Filing Details

Accession Number:
0000899243-22-001270
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-06 19:43:35
Reporting Period:
2021-12-31
Accepted Time:
2022-01-06 19:43:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851657 Vaxxinity Inc. VAXX Pharmaceutical Preparations (2834) 862083865
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1892299 James Chui C/O Vaxxinity, Inc
1717 Main St, Ste 3388
Dallas TX 75201
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-12-31 6,000 $5.48 14,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Class A Common Stock Stock option (right to buy) $4.12 2031-03-01 464,680 464,680 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2031-03-01 464,680 464,680 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.41 to $5.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
  2. These options are currently exercisable.